[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "Chimeric Antigen Receptor (CAR)",
            "T-cells",
            "Prostate-Specific Membrane Antigen (PSMA)",
            "Prostate Cancer"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "Tmunity Therapeutics",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Confirmed histologic diagnosis of prostate cancer and have mCRPC, with castrate levels of testosterone (<50 ng/mL)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "PSA measurable disease per Prostate Working Group 3 (PCWG3) criteria"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Prior therapies defined as at least 2 prior lines of systemic therapy for prostate cancer, including at least one second generation androgen receptor inhibitor and/or CYP17\u03b1 inhibitor. At least one line of prior therapy must be in the mCRPC setting"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Estimated estimated glomerular filtration rate \u2265 60 mL/min by Modification of Diet in Renal Disease criteria"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) \u2264 2.5x the upper limit of normal (ULN); patients with hepatic metastases ALT and AST \u2264 3.0 x ULN"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Serum total bilirubin < 1.5 mg/dL unless patient has known Gilbert's Syndrome, then serum bilirubin \u22643 mg/dL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Serum albumin \u2265 3.0 g/dL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Left ventricular ejection fraction (LVEF) \u2265 50%. LVEF assessment must have been performed within 8 weeks of enrollment"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Hemoglobin \u2265 8 g/dL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Absolute neutrophil count \u2265 1000/\u03bcL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Platelet count \u2265 75,000/\u03bcL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Patients who have not undergone bilateral orchiectomy must be able to continue gonadotropin-releasing hormone (GnRH) therapy during the study"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Eastern Cooperative Oncology Group (ECOG) score of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Toxicities from any previous therapy must have recovered to Grade 1 or baseline"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "Patients of reproductive potential agree to use of approved highly effective contraceptive methods"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Active invasive cancer, other than the proposed cancer included in the study, within 2 years prior to screening, unless treated with curative intent"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Current treatment with systemic corticosteroids (defined as a dose greater than the equivalent of prednisone 10 mg/day)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Active autoimmune disease (including connective tissue disease, uveitis, sarcoidosis, inflammatory bowel disease or multiple sclerosis) or a history of severe autoimmune disease requiring prolonged immunosuppressive therapy (any immunosuppressive therapy within 6 weeks prior to screening visit)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Current human immunodeficiency virus (HIV), hepatitis C virus, hepatitis B virus infections; Patients who are hepatitis B core antigen positive, hepatitis B surface antigen negative, should have a quantitative viral load measured; If viral load is undetectable, the patient will not be excluded if hey are able to be treated with anti-viral medication for at least 7 days prior to lymphodepletion until at least 6 months after infusion with viral load and ALT monitoring"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Active or uncontrolled medical or psychological condition that would preclude participation"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "History of seizure disorder"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Prior allogeneic stem cell transplant"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Central nervous system malignancy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "History of severe infusion reaction to monoclonal antibodies or biological therapies, or to study product excipients that would preclude the patient safely receiving CART-PSMA-TGF\u03b2RDN cells"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "History of being previously treated with a J591 antibody-based therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Ferritin levels \u2265 4x the upper limit of normal prior to apheresis or prior to the start of lymphodepleting chemotherapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Active or recent (within the past 6 months prior to apheresis or lymphodepletion) cardiovascular disease, defined as (1) New York Heart Association Class III or IV heart failure, (2) unstable angina, (3) a history of recent (within 6 months) myocardial infarction or sustained (> 30 second) ventricular tachyarrhythmias, or (4) cerebrovascular accident"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Any active infection currently being treated or any infection within the last 6 weeks that required 7 days or more of IV antibiotics or any active infection within the last 4 weeks that requires use of oral antibiotics. Patients may be eligible once these timeframes elapse and with evidence that the infection has completely resolved"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Have inadequate venous access for or contraindications for the apheresis procedure"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "Must agree not to participate in a conception process or must agree to a highly effective method of contraception"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "MALE",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "This is a Phase 1 single-arm study designed to identify the dose and regimen of CART-PSMA-\r\n      TGF\u03b2RDN cells that can be safely administered intravenously following the lymphodepletion\r\n      (LD) regimen to patients with metastatic castration resistant prostate cancer (mCRPC).\r\n      Following Dose Escalation, a Cohort Expansion will enroll patients to further explore the\r\n      safety and tolerability of the selected dose and schedule.\r\n\r\n      It is anticipated that up to 50 patients will enroll in this study in both dose escalation\r\n      and cohort expansion.",
        "official_title": "A Phase 1 Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients With Metastatic Castration Resistant Prostate Cancer",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Up to 2 years",
                "name": "Cohort Expansion: Safety of CART-PSMA-TGF\u03b2RDN",
                "description": "Percentage of patients experiencing adverse events (AEs), including serious and severe AEs overall, by dose level, and severity grade",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 2 years",
                "name": "Dose Escalation: Dose Identification of CART-PSMA-TGF\u03b2RDN",
                "description": "Incidence of Dose Limiting Toxicity (DLT)",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 2 years",
                "name": "Feasibility of CART-PSMA-TGF\u03b2RDN",
                "description": "Proportion of patients who did not receive CART-PSMA-TGF\u03b2RDN cells",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 15 years",
                "name": "Peripheral expansion and persistence of CART-PSMA-TGF\u03b2RDN",
                "description": "Quantitative polymerase chain reaction (qPCR)",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 2 years",
                "name": "Preliminary efficacy of CART-PSMA-TGF\u03b2RDN as assessed by biochemical Objective Response Rate (ORR)",
                "description": "ORR defined as the proportion of patients with maximal prostate-specific antigen (PSA) decline of greater than or equal to 50% at 12 weeks post infusion",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04227275",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Testosterone Less than 50 Nanograms per Deciliter",
                    "Testosterone Less than 50 Nanograms/Deciliter"
                ],
                "nci_thesaurus_concept_id": "C157378",
                "name": "Testosterone Less than 50 ng/dL",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C157377",
                    "C77140"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C157377",
                "name": "Testosterone Level Finding",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36292",
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C129259",
                "name": "Castration Levels of Testosterone",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C157377",
                    "C36292",
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C157377"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2021-05-12",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Castration-Resistant Prostate Carcinoma",
                    "Castration-Resistant Prostate Carcinoma",
                    "CRPC"
                ],
                "nci_thesaurus_concept_id": "C130234",
                "name": "Castration-Resistant Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8946",
                    "C167255"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Prostate Carcinoma AJCC v8",
                    "Stage IV Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140173",
                "name": "Stage IV Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140163"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Prostate Cancer AJCC v8",
                    "Stage IVA Prostate Carcinoma AJCC v8",
                    "IVA"
                ],
                "nci_thesaurus_concept_id": "C140174",
                "name": "Stage IVA Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "IVB",
                    "Stage IVB Prostate Carcinoma AJCC v8",
                    "Stage IVB Prostate Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C140175",
                "name": "Stage IVB Prostate Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C140173"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Carcinoma Metastatic",
                    "Prostate Cancer Metastatic",
                    "Metastatic Prostate Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C8946",
                "name": "Metastatic Prostate Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C146893"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disorder of Male Reproductive System",
                    "Male Reproductive System Disease"
                ],
                "nci_thesaurus_concept_id": "C27019",
                "name": "Male Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167255",
                "name": "Refractory Prostate Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4863",
                    "C177149"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of Prostate",
                    "Prostate cancer, NOS",
                    "Cancer of Prostate",
                    "Prostate Carcinoma",
                    "Carcinoma of the Prostate",
                    "Cancer of the Prostate"
                ],
                "nci_thesaurus_concept_id": "C4863",
                "name": "Prostate Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181196",
                    "C7378"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of the Prostate",
                    "Neoplasm of Prostate",
                    "Prostate Tumor",
                    "Tumor of the Prostate",
                    "Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C3343",
                "name": "Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C26865"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150534",
                "name": "Refractory Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "resistant cancer",
                    "Refractory Cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Male Reproductive System",
                    "Malignant Male Reproductive System Tumor",
                    "Male reprod. system cancer, NOS",
                    "Malignant Neoplasm of the Male Reproductive System",
                    "Malignant Tumor of Male Reproductive System",
                    "Malignant Neoplasm of Male Reproductive System",
                    "Male reproductive system cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C8561",
                "name": "Malignant Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3054",
                    "C36076"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Genitourinary Neoplasm",
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181196",
                "name": "Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C164141"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genitourinary Disorder",
                    "Urogenital Disease"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Prostate Disease"
                ],
                "nci_thesaurus_concept_id": "C26865",
                "name": "Prostate Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of Male Reproductive System",
                    "Tumor of the Male Reproductive System",
                    "Neoplasm of Male Reproductive System",
                    "Neoplasm of the Male Reproductive System",
                    "Male Reproductive System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3054",
                "name": "Male Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3674",
                    "C27019"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C177149",
                "name": "Refractory Male Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C181196",
                    "C150534",
                    "C8511"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Neoplasm of Prostate",
                    "Malignant Tumor of the Prostate",
                    "Malignant Neoplasm of the Prostate",
                    "Malignant Prostate Tumor",
                    "Malignant Tumor of Prostate"
                ],
                "nci_thesaurus_concept_id": "C7378",
                "name": "Malignant Prostate Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8561",
                    "C3343"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma",
                    "Metastatic Urogenital Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C164141",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of the Reproductive System",
                    "Tumor of Reproductive System",
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156482",
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Malignant Genitourinary System Neoplasm",
                    "Metastatic Genitourinary System Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C8511",
                "name": "Refractory Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Prostate Carcinoma by AJCC v8 Stage",
                    "Tumor Stage (Pathologic)"
                ],
                "nci_thesaurus_concept_id": "C140163",
                "name": "Prostate Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4863"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "CART-PSMA-TGF\u03b2RDN-02",
        "active_sites_count": 3,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Genetically-altered Immune Cell",
                            "Cell-based Gene Therapy Agent",
                            "Genetically-modified Immune Cell"
                        ],
                        "nci_thesaurus_concept_id": "C154231",
                        "name": "Genetically-engineered Immune Cell",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1962",
                            "C142078"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1094",
                        "name": "Fludarabine",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2150",
                            "C1556"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunosuppressive Agents"
                        ],
                        "nci_thesaurus_concept_id": "C574",
                        "name": "Immunosuppressant",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2486",
                        "name": "Recombinant Interleukin-1 Receptor Antagonist",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C574"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Purine Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C1556",
                        "name": "Purine Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C272"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biologicals",
                            "Immunologics",
                            "Biological Products",
                            "Biopharmaceuticals",
                            "Immunologic, Immunochemical",
                            "Biologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapeutic Agent",
                            "BRM",
                            "Immune Modulators",
                            "Immunomodulatory Agent",
                            "Biomodulators",
                            "Immunomodulators",
                            "Immunopotentiators",
                            "Immune Regulators",
                            "Biological Response Modifier",
                            "Immunomodulating Agent",
                            "Immunotherapy Agent",
                            "Immune Mediators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunosuppressive Agents"
                        ],
                        "nci_thesaurus_concept_id": "C574",
                        "name": "Immunosuppressant",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C148496",
                        "name": "Autologous PSMA-specific TGFb-resistant CAR T Cells",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C137999"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CAR-modified T-cells",
                            "CAR T-cells",
                            "CAR-T Cell",
                            "CAR T Cells",
                            "CAR-T Cells",
                            "Chimeric-antigen Receptor T-lymphocytes",
                            "Chimeric Antigen Receptor T-cells",
                            "CAR T Cell"
                        ],
                        "nci_thesaurus_concept_id": "C137999",
                        "name": "Chimeric Antigen Receptor T-Cell Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C154231"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2114",
                        "name": "Mustard Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1590"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiangiogenic Agent",
                            "Angiogenesis Antagonists",
                            "Anti-Angiogenic Agents",
                            "Angiogenesis Blockers",
                            "Antiangiogenesis Agents"
                        ],
                        "nci_thesaurus_concept_id": "C1742",
                        "name": "Angiogenesis Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2150",
                        "name": "Ribonucleotide Reductase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Kineret"
                        ],
                        "nci_thesaurus_concept_id": "C38717",
                        "name": "Anakinra",
                        "description": "A recombinant human nonglycosylated interleukin-1 (IL-1) receptor antagonist with potential antineoplastic activity. Anakinra binds to the IL-1 receptor, thereby blocking the binding of the IL-1 to and activation of its receptor. Blockade of IL-1 activity may inhibit the cascade of downstream pro-angiogenic factors such as vascular endothelial cell growth factor, tumor necrosis factor-alpha, and IL-6, resulting in inhibition of tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C2486",
                            "C1742"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antimetabolites"
                        ],
                        "nci_thesaurus_concept_id": "C272",
                        "name": "Antimetabolite",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Drug Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "ACT Agent",
                            "Adoptive Cell Therapy Agent",
                            "Adoptive Cell-based Agent",
                            "Adoptive Cell Transfer Agent",
                            "Adoptive Cellular Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C142078",
                        "name": "Adoptive Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C697",
                        "name": "Nitrogen Mustard Compound",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2114"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Gene Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1962",
                        "name": "Gene Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2842",
                        "name": "DNA Binding Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapy Alkylators",
                            "Chemotherapy Alkylating Agents"
                        ],
                        "nci_thesaurus_concept_id": "C1590",
                        "name": "Antineoplastic Alkylating Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2842"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceutical Agent",
                            "Drug Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapeutic Agent",
                            "BRM",
                            "Immune Modulators",
                            "Immunomodulatory Agent",
                            "Biomodulators",
                            "Immunomodulators",
                            "Immunopotentiators",
                            "Immune Regulators",
                            "Biological Response Modifier",
                            "Immunomodulating Agent",
                            "Immunotherapy Agent",
                            "Immune Mediators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Cyclostin",
                            "CYCLO-cell",
                            "Cytophosphan",
                            "Cycloblastin",
                            "Fosfaseron",
                            "Cicloxal",
                            "Carloxan",
                            "Cycloblastine",
                            "Genoxal",
                            "Cyclostine",
                            "Ledoxina",
                            "Genuxal"
                        ],
                        "nci_thesaurus_concept_id": "C405",
                        "name": "Cyclophosphamide",
                        "description": "A synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities.  In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C574",
                            "C697"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Dose Escalation",
                "description": "Dose escalation of intravenous CART-PSMA-TGF\u03b2RDN cells for patients with metastatic castration resistant prostate cancer",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2020-00506",
        "why_study_stopped": null,
        "brief_summary": "Multi-center, open-label, Phase 1 study of the safety, tolerability and feasibility of dosing\r\n      patients harboring metastatic castration resistant prostate cancer (mCRPC) with genetically\r\n      modified autologous T cells (CART-PSMA-TGF\u03b2RDN cells) engineered to express a chimeric\r\n      antigen receptor (CAR) capable of recognizing the tumor antigen prostate-specific membrane\r\n      antigen (PSMA) and activating the T cell.",
        "brief_title": "A Study of CART-PSMA-TGF\u03b2RDN in Patients With Metastatic Castration Resistant Prostate Cancer",
        "status_history": [
            {
                "status_date": "2021-05-12T00:00:00.000005",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2021-02-24T00:00:00.000004",
                "status": "ACTIVE"
            },
            {
                "status_date": "2021-01-05T00:00:00.000003",
                "status": "TEMPORARILY_CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2020-05-25T00:00:00.000002",
                "status": "ACTIVE"
            },
            {
                "status_date": "2020-03-23T00:00:00.000001",
                "status": "TEMPORARILY_CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2019-11-22T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 50,
        "_current_trial_status_sort_order": 7,
        "start_date": "2019-11-22",
        "record_verification_date": "2021-05-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Prostate"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2036-11-30",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]